Company / Book Value per Share
Anika Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$9.952
FY2025
5-year range
$9.952 / $20.125
FY2021-FY2025
Trend
-5.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 4 consecutive years, from $20.125 in FY2021 to $9.952 in FY2025.
Based on SEC 10-K filings.
$9.952 in FY2025 with a 5-year CAGR of -11.6%.
Declined from $14.514 to $9.952 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -19.2%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Anika Therapeutics, Inc.'s book value per share has declined for 4 consecutive years.
- 5-year CAGR of -11.6%, indicating a declining trend.
- In FY2025, book value per share decreased 5.3% year-over-year.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.952 | -5.3% |
| FY2024 | $10.504 | -27.6% |
| FY2023 | $14.514 | -23.1% |
| FY2022 | $18.863 | -6.3% |
| FY2021 | $20.125 | +9.3% |
| FY2020 | $18.416 | -0.7% |
| FY2019 | $18.543 | +22.3% |
| FY2018 | $15.167 | +5.2% |
| FY2017 | $14.415 | +21.7% |
| FY2016 | $11.844 | +29.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026